The efficacy of antimalarial drug treatment is compromised by the malaria parasite’s potential to build drugresistance, and by the dearth of new and effective antimalarials in the drug-layout pipeline
Next, the Mitf mutant ventral RPE does not undergo re-specification as long as two...